Work

Abstract P1-12-04: Phase I dose-escalation trial of ONT-380 in combination with trastuzumab in patients (pts) with HER2+ breast cancer brain metastases

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs16-p1-12-04

Authors: O Metzger, W Barry, I Krop, H Guo, J Younger, E Lawler, L Walker, R Freedman, S Tolaney, E Winer, N Lin

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2592316547

Cites:

Cited by: 4

Related to: 10